This inventor holds 18 USPTO granted patents and 30 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Actinium Pharmaceuticals, Limited, Eli Lilly and Company, Imclone LLC. Active years: 2002-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Randolph, NJ (US) (2009 - 2011)
- Denville, NJ (US) (2016 - 2019)
- Rockaway, NJ (US) (2002 - 2024)
Company Filing History:
8 out of 32 
4 out of 4,517 
4 out of 26 
Years Active: 2002-2026
Areas of Expertise:
Title: Innovations by Inventor Dale Lincoln Ludwig
Introduction
Dale Lincoln Ludwig is a distinguished inventor based in Rockaway, NJ, USA, recognized for his contributions to the field of biotechnology and therapeutic innovations. With a remarkable portfolio, he holds a total of 11 patents, reflecting his dedication to advancing medical treatments and improving patient outcomes.
Latest Patents
Among Ludwig's latest innovations is the patent for "Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies." This invention introduces a novel method for depleting a subject's hematopoietic stem cells through the administration of a radiolabeled anti-CD45 antibody, such as I-BC8 or Ac-BC8. Additionally, it outlines a treatment approach for non-cancerous disorders that involve genetically edited cell therapy, emphasizing the effective application of this method.
Another significant patent focuses on "Anti-PD-L1-anti-TIM-3 bispecific antibodies." This invention involves heterodimeric antibodies that bind to human PD-L1 and human TIM-3, which may offer promising treatment options for cancer, both independently and in conjunction with chemotherapy and other cancer therapeutics.
Career Highlights
Dale Lincoln Ludwig has had an impactful career, working with notable companies such as Eli Lilly and Company and ImClone LLC, where he has contributed to significant advancements in medical technology. His expertise in antibody development and gene-edited therapies has garnered attention in the biotech community.
Collaborations
Throughout his career, Ludwig has collaborated with talented individuals, including Yiwen Li and Yang Shen, who have contributed to the research and development of his innovative therapies. These partnerships reflect a strong commitment to collective advancements in biotechnology.
Conclusion
Dale Lincoln Ludwig's impressive array of patents showcases his innovative spirit and dedication to enhancing medical treatments. His work in developing cutting-edge therapies has the potential to revolutionize the landscape of healthcare, providing new hope to patients facing challenging medical conditions. As he continues to push the boundaries of science and technology, Ludwig remains a prominent figure in the world of biotechnology and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile